You are browsing the Hong Kong website, Regulated by Hong Kong SFC (CE number: BJA907). Investment is risky and you must be cautious when entering the market.
萬方發展(000638.SZ):子公司與中科院蘇州醫工所簽署戰略合作協議
格隆匯 03-15 16:06

格隆匯 3 月 15日丨萬方發展(000638.SZ)公佈,公司控股子公司萬方百奧(乙方)於2021年3月11日與中科院蘇州醫工所(甲方)簽訂《戰略合作協議》,約定雙方合作共建“中科院蘇州醫工所萬方百奧生物技術研究中心/實驗室”(“研究中心”),以技術為牽引、市場需求為目標,合作研發雙方認同的高端醫療器械、疫苗免疫效果評價和第三方檢測試劑等相關產品,共同組成一支緊密合作的研發、工程化、產業化團隊,形成一批具有自主知識產權的成果和技術。

甲、乙雙方對包括但不限於生物醫藥、疫苗、疫苗免疫評價、高端醫療器械、第三方檢測平台等領域的市場前景一致看好,且各方在該領域的合作能充分發揮各自的優勢與核心競爭力。其中甲方已建成科技創新與工程化的研發平台,在研發疫苗免疫效果評價方法和第三方檢測試劑等方面取得了部分階段性成果;乙方擁有國內領先的生物技術研發及轉化平台建設解決方案,擁有疫苗、重組蛋白類藥物、疫苗免疫效果評價方法、第三方檢測平台等產品的開發、生產、銷售及市場能力。

此次戰略合作協議的簽署,有利於公司迅速搭建與中科院合作的科研平台,並聯合其專業的科研團隊和研發平台,加快在高端醫療器械創新技術、疫苗免疫效果評價和第三方檢測試劑等領域取得自主知識產權成果並實現產業化落地,拓寬公司在生物製品板塊的佈局,符合全體股東的利益和公司長遠發展戰略。公司預計該項合作短期內不會對公司的財務狀況造成重大影響。

Follow us
Find us on Facebook, Twitter , Instagram, and YouTube or frequent updates on all things investing.Have a financial topic you would like to discuss? Head over to the uSMART Community to share your thoughts and insights about the market! Click the picture below to download and explore uSMART app!
Disclaimers
uSmart Securities Limited (“uSmart”) is based on its internal research and public third party information in preparation of this article. Although uSmart uses its best endeavours to ensure the content of this article is accurate, uSmart does not guarantee the accuracy, timeliness or completeness of the information of this article and is not responsible for any views/opinions/comments in this article. Opinions, forecasts and estimations reflect uSmart’s assessment as of the date of this article and are subject to change. uSmart has no obligation to notify you or anyone of any such changes. You must make independent analysis and judgment on any matters involved in this article. uSmart and any directors, officers, employees or agents of uSmart will not be liable for any loss or damage suffered by any person in reliance on any representation or omission in the content of this article. The content of the article is for reference only and does not constitute any offer, solicitation, recommendation, opinion or guarantee of any securities, virtual assets, financial products or instruments. Regulatory authorities may restrict the trading of virtual asset-related ETFs to only investors who meet specified requirements. Any calculations or images in the article are for illustrative purposes only.
Investment involves risks and the value and income from securities may rise or fall. Past performance is not indicative of future performance. Please carefully consider your personal risk tolerance, and consult independent professional advice if necessary.
uSMART
Wealth Growth Made Easy
Open Account